| June 17, 2013 |
| Bombardier Discloses Odyssey as European Customer for 10 CSeries Aircraft |
| PARIS, FRANCE--(Marketwired - June 17, 2013) - Bombardier Aerospace disclosed today that a previously announced firm order for 10 CS100 aircraft was placed by Odyssey Airlines, a new airline that intends to operate from London City Airport. The firm order was announced on June 24, 2011. Based on the list price for the CS100 aircraft at the time of the order, the firm order is valued at $628 million US. "We are launching Odyssey Airlines with the CS100 aircraft because its transcontinental range will allow us to connect key city airports with stringent performance and environmental requirements both in Europe and further afield," said Adam D. Scott, Chief Executive Officer, Odyssey Airlines. "We have a unique strategy that will offer a premier service with a focus on new destinations that cannot currently be served from London City Airport. For us, the game-changing CSeries aircraft offers the best-in-class airfield performance, the lowest sound profile of any commercial aircraft in production in its segment, and will provide the ability to open new markets -- all of which are integral to our business model." "Over the last two years, Bombardier has seen Odyssey evolve into a forward-thinking and up-and-coming airline. We are thrilled to publicly welcome Odyssey Airlines to the family of CS100 aircraft operators," said Mike Arcamone, President, Bombardier Commercial Aircraft. "The CSeries aircraft's premium cabin, reduced environmental footprint and fantastic ability to serve a wide range of missions are the perfect pairing to Odyssey's business plan," he added. About CSeries Aircraft Designed for the growing 100- to 149-seat market, the 100 per cent new CSeries aircraft family combines advanced materials, leading-edge technology and proven methods to meet commercial airline requirements. Powered by Pratt & Whitney PurePower PW1500G engines, the CSeries aircraft family will offer a 15(i) per cent cash operating cost advantage and a 20(i) per cent fuel burn advantage. With the extra capacity seating option, the CS300 aircraft's productivity further improves, offering airlines an average of four(i) per cent additional cash operating cost advantage per seat. The CSeries aircraft's clean-sheet design is ensuring that the aircraft will achieve greatly reduced noise and emissions, as well as superior operational flexibility, exceptional airfield performance and a range of 2,950 nm (5,463 km)(i). The CSeries aircraft will be up to 12,000 lbs. (5,443 kg)(i) lighter than other aircraft in the same seat category and will provide passengers with a best-in-class, widebody cabin environment in a single-aisle aircraft. As of March 31, 2013, Bombardier had booked orders and commitments for 388 CSeries aircraft, which included firm orders for 145 CSeries airliners. About Bombardier Bombardier is the world's only manufacturer of both planes and trains. Looking far ahead while delivering today, Bombardier is evolving mobility worldwide by answering the call for more efficient, sustainable and enjoyable transportation everywhere. Our vehicles, services and, most of all, our employees are what make us a global leader in transportation. Bombardier is headquartered in Montreal, Canada. Our shares are traded on the Toronto Stock Exchange (BBD) and we are listed on the Dow Jones Sustainability World and North America Indexes. In the fiscal year ended December 31, 2012, we posted revenues of $16.8 billion. News and information are available at bombardier.com or follow us on Twitter @Bombardier. Notes to editors Images of Odyssey Airlines' CSeries aircraft are available in the press releases section at: www.bombardier.com . For additional images, video and product information on CSeries aircraft, please visit: www.cseries.com . Follow @Bombardier_Aero on Twitter to receive the latest news and updates from Bombardier Aerospace. For information about Bombardier Aerospace's presence at the 2013 International Paris Air Show, please visit airshows.bombardier.com. (i) The CSeries aircraft are in the development phase. All data and specifications are estimates, subject to changes in family strategy, branding, capacity and performance during the development, manufacture and certification process. All performance references have been estimated based on a 500-nm North American operating environment and comparisons are to in-production aircraft. Bombardier, CS100, CS300, CSeries and The Evolution of Mobility are trademarks of Bombardier Inc. or its subsidiaries. www.bombardier.com |
| |
| CONTACT INFORMATION: |
| Bombardier Commercial Aircraft Marc Duchesne 1-416-375-3030 marc.duchesne@aero.bombardier.com www.bombardier.com |
| INDUSTRY: Aerospace and Defense - Aircraft, Aerospace and Defense - Electronics and Communications, Aerospace and Defense - Land Vehicles |
Bombardier Inc. (BDRBF: OTCQX International Premier) |
Top 10 Most Recent News Articles
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List
A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...
Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue ReadingTop 5 Most Recently Viewed Articles
Transocean Ltd. Scheduled Earnings Conference Call for Q3 2024
Transocean Ltd. Earnings Release Announcement Transocean Ltd. has officially announced that it will be releasing its third quarter earnings for 2024. The earnings report is scheduled for Wednesday, October 30, 2024. This release is highly anticipated as it aims to provide stakeholders with insights regarding the company's performance in the offshore contract drilling...
Continue Reading
Stride, Inc. Faces Class Action as Investors Seek Justice
Stride, Inc. Faces Securities Lawsuit Stride, Inc. (NYSE: LRN), a prominent educational service provider, finds itself embroiled in a class action lawsuit alleging serious violations of securities laws. Investors who feel wronged are encouraged to engage with experienced legal counsel to explore their options. The law firm Levi & Korsinsky, known for its adept handling of...
Continue Reading
Amazon's Prime Day and Golden Cross: A Bullish Outlook
Amazon's Market Dynamics and Performance Insights In today's ever-evolving technology sector, companies often evaluate key performance indicators (KPIs) that forecast their future success. Amazon.com (NASDAQ: AMZN) exemplifies this, boasting a market capitalization of $2.3 trillion. Each year, Amazon's Prime Day is a highlight for online shoppers, offering discounts that...
Continue Reading
Previewing Lam Research's Upcoming Earnings Release
Preparing for Lam Research's Earnings Announcement Lam Research (NASDAQ:LRCX) is gearing up for its next quarterly earnings report. Investors are anxious for an update, especially with anticipation building around the company’s performance. Understanding the upcoming earnings can provide crucial insights into Lam Research’s potential growth trajectory. What Analysts...
Continue Reading
AAR CORP. Announces Public Offering of 3 Million Shares
AAR CORP. Pricing of Public Offering AAR CORP. ('AAR' or the 'Company') (NYSE: AIR) has officially announced the pricing of a significant underwritten public offering encompassing 3,000,000 shares of its common stock. The shares are being offered at a set price of $83.00 per share, with the underwriters given a 30-day option to acquire an extra 450,000 shares from AAR at...
Continue Reading